Skip to main content
. 2022 Nov 29;10(6):e01962-22. doi: 10.1128/spectrum.01962-22

TABLE 3.

Diagnostic performance of the in-house-developed nsp8 and N gene RT-LAMP-CRISPR assays compared to the LightMix E gene RT-PCR assay for SARS-CoV-2 detection

Molecular assay Molecular assay result LightMix E gene RT-PCR
Sensitivity (%) Kappa value (95% CI)a P value by McNemar’s test
Positive Negative
nsp8 RT-LAMP-CRISPR
 Nasopharyngeal specimensb Positive 78 0 100 1 1
Negative 0 71
 Saliva specimensc Positive 68 0 97.1 0.976 (0.942–1) 0.5
Negative 2e 100
 All specimensd Positive 146 0 98.6 0.987 (0.97–1) 0.5
Negative 2e 171
N RT-LAMP-CRISPR
 Nasopharyngeal specimensb Positive 78 0 100 1 1
Negative 0 71
 Saliva specimensc Positive 68 0 97.1 0.976 (0.942–1) 0.5
Negative 2e 100
 All specimensd Positive 146 0 98.6 0.987 (0.97–1) 0.5
Negative 2e 171
a

CI, confidence interval.

b

Median Cp, 21.8 (range, 14.2 to 33.5).

c

Median Cp, 24.7 (range, 14.6 to 36.6).

d

Median Cp, 23.1 (range, 14.2 to 36.6).

e

The Cp values were 36.2 and 36.6.